ArticleRSC advances2018
Development of a high-throughput and sensitive assay of fusion genes in lung cancer by array-based MALDI-TOFMS.
Han-Tao Wu, Kun Li, Gang Wang, Xue-Xi Yang, Anna Zhu, Xu-Ping Xu, Ming Li, Ying-Song Wu, Tian-Cai Liu
Open access · goldAbstract read
In one paragraphArticle in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 2 institutions in 2 countries.
Han-Tao WuInstitute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University Guangzhou 510515 Guangdong P. R. China wg@smu.edu.cn liutc@smu.edu.cn +86-20-37247604 +86-20-62789355.
Kun LiInstitute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University Guangzhou 510515 Guangdong P. R. China wg@smu.edu.cn liutc@smu.edu.cn +86-20-37247604 +86-20-62789355.
Gang WangInstitute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University Guangzhou 510515 Guangdong P. R. China wg@smu.edu.cn liutc@smu.edu.cn +86-20-37247604 +86-20-62789355.
Xue-Xi YangInstitute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University Guangzhou 510515 Guangdong P. R. China wg@smu.edu.cn liutc@smu.edu.cn +86-20-37247604 +86-20-62789355.
Anna ZhuGuangzhou Darui Biotechnology Co. Ltd. Guangzhou 510665 China.
Xu-Ping XuGuangzhou Darui Biotechnology Co. Ltd. Guangzhou 510665 China.
Ming LiInstitute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University Guangzhou 510515 Guangdong P. R. China wg@smu.edu.cn liutc@smu.edu.cn +86-20-37247604 +86-20-62789355.
Ying-Song WuInstitute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University Guangzhou 510515 Guangdong P. R. China wg@smu.edu.cn liutc@smu.edu.cn +86-20-37247604 +86-20-62789355.
Tian-Cai LiuInstitute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University Guangzhou 510515 Guangdong P. R. China wg@smu.edu.cn liutc@smu.edu.cn +86-20-37247604 +86-20-62789355.ORCID https://orcid.org/0000-0002-2985-3766 Southern Medical University · CNKai Biotech (South Korea) · KR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
ALK (anaplastic lymphoma kinase gene),
Identifiers
PMID35548167
PMCPMC9087866
OpenAlexW2887848569
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390